Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,680,328 papers from all fields of science
Search
Sign In
Create Free Account
Aldesleukin
Known as:
Interleukin-2(2-133),125-ser
, aldesleukin [Chemical/Ingredient]
, Recombinant Human IL-2
Expand
A recombinant analog of the endogenous cytokine interleukin-2 (IL-2) with immunoregulatory and antineoplastic activities. Aldesleukin binds to and…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
46 relations
Aldesleukin 22000000 UNT Injection [Proleukin]
Biomed 101/interleukin-2
Cardiac Tamponade
Decreased Ventilatory Gas Flow [PE]
Expand
Broader (3)
Anti-HIV Agents
Antineoplastic Agents
Recombinant Proteins
Narrower (1)
Proleukin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Efficacy and safety of recombinant human interleukin-2 in the adjuvant treatment of relapsing infiltrative pulmonary tuberculosis
Deguang Cui
,
Wenjuan Zhu
2014
Corpus ID: 20235548
Objective: To study the efficacy and safety of recombinant human interleukin-2 in the adjuvant treatment of relapsing…
Expand
2011
2011
A phase II clinical trial of recombinant human interleukin-2 in treatment of advanced melanoma
B. Tang
,
L. Si
,
+4 authors
Jun Guo
2011
Corpus ID: 76163823
Objective: To investigate the efficacy and safety of high-dose recombinant human interleukin-2 (rhIL-2) in treatment of patients…
Expand
1999
1999
The effect of pH and temperature on the conformational stability of recombinant human interleukin-2
Parina Khosroshahroudi Gounili
1999
Corpus ID: 82774547
1994
1994
Treatment of Metastatic Colorectal Cancer Patients with 5-Fluorouracil in Combination with Recombinant Subcutaneous Human lnterleukin-2 and Alpha-lnterferon
J. Atzpodien
,
H. Kirchner
,
+5 authors
H. Poliwoda
1994
Corpus ID: 262471911
We treated 14 patients with progressive metastatic colorectal cancer, using a combination of subcutaneous recombinant human…
Expand
1992
1992
Hematopoietic growth-promoting effects of natural killer cells in mice in response to in vivo administration of human interleukin-2.
W. Murphy
,
D. Longo
Journal of the National Cancer Institute
1992
Corpus ID: 23967822
BACKGROUND Interleukin-2 (IL-2) is currently being evaluated as an anti-neoplastic agent because of its stimulatory effects on…
Expand
1992
1992
Recombinant interleukin-2 alone did not induce proteinuria with changes in anionic sites of the glomerular basement membrane in rats.
S. Fujimoto
,
Y. Yamamoto
,
S. Hisanaga
,
N. Yokota
,
T. Eto
Nephron
1992
Corpus ID: 920290
Shouichi Fujimoto, MD, First Department of Internal Medicine, Miyazaki Medical College 5200, Kihara, Kiyotake, Miyazaki 889-16…
Expand
1990
1990
Hyperbilirubinaemia in patients treated with recombinant human interleukin-2 (rIL-2)
C. Punt
,
S. Henzen‐Logmans
,
R. Bolhuis
,
G. Stoter
British Journal of Cancer
1990
Corpus ID: 37295913
Sir Thus far, we have treated 22 patients with rIL-2 (Cetus, Emeryville, CA, USA) alone, with chemotherapy or with ex vivo rIL-2…
Expand
1989
1989
Renal allograft rejection: possible involvement of lymphokine-activated killer cells.
John A. Kirby
,
J. Forsythe
,
G. Proud
,
R. Taylor
Immunology
1989
Corpus ID: 11828401
Human renal allograft tissue was recovered at transplant nephrectomy from three patients with irreversible loss of graft function…
Expand
Highly Cited
1987
Highly Cited
1987
Prophylactic administration of interleukin-2 protects mice from lethal challenge with gram-negative bacteria
K. Chong
Infection and Immunity
1987
Corpus ID: 37611996
Prophylactic administration of recombinant human interleukin-2 (IL-2) in mice enhanced survival and produced complete recovery…
Expand
1987
1987
[Adoptive immunotherapy of cancer patients with lymphokine-activated killer cells].
T. Taguchi
,
K. Domoto
Gan to kagaku ryoho. Cancer & chemotherapy
1987
Corpus ID: 19732397
We have examined the effects of recombinant human interleukin-2 (rIL-2) on generation of lymphokine-activated killer (LAK) cells…
Expand